On July 2nd local time, the Japanese Ministry of Health, Labour and Welfare released information stating that according to a report from Kobayashi Pharmaceutical, as of June 30, the cumulative number of people receiving medical treatment in institutions related to health products containing red yeast rice ingredients manufactured by the company has increased to 2221, with the cumulative number of hospitalized patients increasing to 492.
超2200人服用小林制药问题保健品后接受治疗
Over 2200 people receiving treatment after taking problem health products from Kobayashi Pharmaceutical.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.